Prelude Capital Management, LLC Myriad Genetics Inc Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $61,152 - $99,423	-5,029 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $53,572 - $70,239	4,762 Added 1783.52%	5,029 $66,000
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $2,854 - $4,402	267 New	267 $3,000
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $7,594 - $9,785	-282 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $3,213 - $5,376	118 Added 71.95%	282 $8,000
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $9,505 - $12,736	-253 Reduced 60.67%	164 $8,000
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $11,571 - $16,750	417 New	417 $16,000

232

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.22B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.